BG61340B1 - Benzene-dimethanol derivative, suitable micronizating - Google Patents

Benzene-dimethanol derivative, suitable micronizating Download PDF

Info

Publication number
BG61340B1
BG61340B1 BG97767A BG9776793A BG61340B1 BG 61340 B1 BG61340 B1 BG 61340B1 BG 97767 A BG97767 A BG 97767A BG 9776793 A BG9776793 A BG 9776793A BG 61340 B1 BG61340 B1 BG 61340B1
Authority
BG
Bulgaria
Prior art keywords
salt
organic
microcrystals
hot
hydroxy
Prior art date
Application number
BG97767A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG97767A (bg
Inventor
Stephen F Beach
David W Latham
Tony G Roberts
Colin B Sidgwick
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BG97767A publication Critical patent/BG97767A/bg
Publication of BG61340B1 publication Critical patent/BG61340B1/bg

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
BG97767A 1990-11-29 1993-05-25 Benzene-dimethanol derivative, suitable micronizating BG61340B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909026005A GB9026005D0 (en) 1990-11-29 1990-11-29 Drug material suitable for micronisation
PCT/GB1991/002108 WO1992009557A1 (en) 1990-11-29 1991-11-28 Benzenedimethanol suitable for micronisation

Publications (2)

Publication Number Publication Date
BG97767A BG97767A (bg) 1994-12-02
BG61340B1 true BG61340B1 (en) 1997-06-30

Family

ID=10686212

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97767A BG61340B1 (en) 1990-11-29 1993-05-25 Benzene-dimethanol derivative, suitable micronizating

Country Status (27)

Country Link
US (1) US5380922A (cs)
EP (2) EP0639176B1 (cs)
JP (1) JP3375626B2 (cs)
KR (1) KR100192196B1 (cs)
AT (1) ATE144244T1 (cs)
AU (1) AU644505B2 (cs)
BG (1) BG61340B1 (cs)
CA (1) CA2099586C (cs)
CY (1) CY2009A (cs)
CZ (1) CZ282996B6 (cs)
DE (1) DE69122780T2 (cs)
DK (1) DK0639176T3 (cs)
ES (1) ES2093812T3 (cs)
FI (2) FI118155B (cs)
GB (1) GB9026005D0 (cs)
GR (1) GR3022088T3 (cs)
HK (1) HK78997A (cs)
HU (1) HU218205B (cs)
IE (1) IE914146A1 (cs)
OA (2) OA09861A (cs)
PL (2) PL169722B1 (cs)
RU (2) RU2197475C2 (cs)
SG (1) SG49741A1 (cs)
SK (1) SK281095B6 (cs)
TW (1) TW309425B (cs)
WO (1) WO1992009557A1 (cs)
ZA (1) ZA919401B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
WO1993016031A1 (en) * 1992-02-11 1993-08-19 Glaxo Group Limited Benzenedimethanol derivative suitable for micronisation
US6254882B1 (en) 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
JP2002541183A (ja) 1999-04-14 2002-12-03 グラクソ グループ リミテッド 医薬用エアゾール製剤
WO2002026239A1 (en) 2000-09-26 2002-04-04 Temple University Of The Commonwealth System Of Higher Education Analgesic and glucosamine compositions
EP2127641A1 (en) 2008-05-26 2009-12-02 Inke, S.A. Micronisable form of salmeterol xinafoate
KR101100614B1 (ko) 2010-09-20 2011-12-29 한국수력원자력 주식회사 농축폐액 건조물의 펠렛화 장치 및 방법과 이를 이용한 유리조성개발 방법
WO2016142582A1 (en) 2015-03-11 2016-09-15 Fermion Oy Process for the preparation of crystalline salmeterol and its xinafoate salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation

Also Published As

Publication number Publication date
FI932422A0 (fi) 1993-05-27
KR100192196B1 (en) 1999-06-15
FI982081A0 (fi) 1998-09-28
CY2009A (en) 1998-02-20
US5380922A (en) 1995-01-10
EP0639176B1 (en) 1996-10-16
DK0639176T3 (da) 1996-12-23
TW309425B (cs) 1997-07-01
CZ101993A3 (en) 1994-01-19
CA2099586C (en) 2002-06-25
CZ282996B6 (cs) 1997-12-17
ZA919401B (en) 1992-07-29
OA10024A (en) 1996-10-14
SK54593A3 (en) 1993-10-06
DE69122780D1 (de) 1996-11-21
CA2099586A1 (en) 1992-05-30
OA09861A (en) 1994-08-15
EP0571669B1 (en) 1996-03-06
BG97767A (bg) 1994-12-02
EP0571669A1 (en) 1993-12-01
HUT64219A (en) 1993-12-28
FI118155B (fi) 2007-07-31
PL169722B1 (pl) 1996-08-30
GR3022088T3 (en) 1997-03-31
ES2093812T3 (es) 1997-01-01
EP0639176A1 (en) 1995-02-22
JPH06503082A (ja) 1994-04-07
SG49741A1 (en) 1998-06-15
GB9026005D0 (en) 1991-01-16
PL167976B1 (pl) 1995-12-30
FI118203B (fi) 2007-08-31
RU2197475C2 (ru) 2003-01-27
HK78997A (en) 1997-06-20
AU644505B2 (en) 1993-12-09
AU9040291A (en) 1992-06-25
HU9301568D0 (en) 1993-09-28
RU2116293C1 (ru) 1998-07-27
JP3375626B2 (ja) 2003-02-10
FI982081L (fi) 1998-09-28
DE69122780T2 (de) 1997-02-20
ATE144244T1 (de) 1996-11-15
HU218205B (hu) 2000-06-28
IE914146A1 (en) 1992-06-03
FI932422L (fi) 1993-05-27
SK281095B6 (sk) 2000-11-07
WO1992009557A1 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
FI73128B (fi) Foerfarande foer framstaellning av finmalt beklometason-dipropionat-monohydrat.
JP5317960B2 (ja) 微粉砕化有機化合物粒子の製造方法
TW492877B (en) Process for the preparation of respirable particles
SK158799A3 (en) Composition comprising finely divided, crystalline particles of budesonide
JP2013516394A (ja) 医薬用途用の1−(1h−1,2,4−トリアゾール−1−イル)ブタン−2−オール誘導体、および前記1−(1h−1,2,4−トリアゾール−1−イル)ブタン−2−オール誘導体を調製するための、実質的に不定の結晶形状を有する1−(1h−1,2,4−トリアゾール−1−イル)ブタン−2−オール誘導体の使用
BG61340B1 (en) Benzene-dimethanol derivative, suitable micronizating
CN113271978A (zh) 包括基本上无定形的介孔碳酸镁的新型无定形活性药物成分
Westmeier et al. Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment
KR20140048237A (ko) 플루티카손 프로피오네이트 형태 1의 제조 방법
US20100234469A1 (en) New Crystals Of A Benzoylbenzeneacetamide Derivative
AP323A (en) Drug material suitable for micronisation.
US20040247689A1 (en) Process for preparing a pharmaceutical active ingredient with high specific surface area
WO1993016031A1 (en) Benzenedimethanol derivative suitable for micronisation
SI9200252A (sl) Zdravilni material, primeren za mikronizacijo
CN1056974C (zh) 适宜于微粒化的药物材料的制备方法
IL101798A (en) 1-hydroxy-2-naphthalene carboxylate (hydroxynaphthoate) salt of 4-hydroxy- alpha1-[[[6-4-phenylbutoxy) hexyl] amino] methyl]-1,3-benzenedimethanol suitable for micronisation
WO2009144193A1 (en) Micronisable form of salmeterol xinafoate
US20020072602A1 (en) Micronized mirtazapine
NZ240788A (en) 1-hydroxy-2-naphthalene carboxylate salt of 4-hydroxy- alpha 1
KR20250141819A (ko) 용해도가 개선된 새로운 바모롤론 조제물
WO2007064311A1 (en) Micronized mirtazapine